Value Insider Season 1 Episode 1: The Importance of Payers and HTA: How Did We End Up Here? (Introduction to Value) [Podcast]

The importance of payers and HTA: How did we end up here? In this episode of the Value Insider podcast, host Mike Chambers speaks with Prof. Mike Drummond about Health Technology Assessment (HTA) and how value is defined. Prof. Drummond is professor of Health Economics of York University, former pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Drummond, Michael F, Hartgers-Gubbels, Elisabeth Sophia, Chambers, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532943/
https://www.ncbi.nlm.nih.gov/pubmed/36213303
http://dx.doi.org/10.2147/IJGM.S389025
_version_ 1784802233306578944
author Drummond, Michael F
Hartgers-Gubbels, Elisabeth Sophia
Chambers, Michael
author_facet Drummond, Michael F
Hartgers-Gubbels, Elisabeth Sophia
Chambers, Michael
author_sort Drummond, Michael F
collection PubMed
description The importance of payers and HTA: How did we end up here? In this episode of the Value Insider podcast, host Mike Chambers speaks with Prof. Mike Drummond about Health Technology Assessment (HTA) and how value is defined. Prof. Drummond is professor of Health Economics of York University, former president of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR), and author of two major textbooks in the field, as well as over 700 publications, and has acted as consultant to the WHO as well as European Union with regards to value assessment. Starting from the very beginning, Prof. Drummond explains in a simple yet engaging way why demonstrating value of new interventions has become so important.
format Online
Article
Text
id pubmed-9532943
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-95329432022-10-06 Value Insider Season 1 Episode 1: The Importance of Payers and HTA: How Did We End Up Here? (Introduction to Value) [Podcast] Drummond, Michael F Hartgers-Gubbels, Elisabeth Sophia Chambers, Michael Int J Gen Med Commentary The importance of payers and HTA: How did we end up here? In this episode of the Value Insider podcast, host Mike Chambers speaks with Prof. Mike Drummond about Health Technology Assessment (HTA) and how value is defined. Prof. Drummond is professor of Health Economics of York University, former president of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR), and author of two major textbooks in the field, as well as over 700 publications, and has acted as consultant to the WHO as well as European Union with regards to value assessment. Starting from the very beginning, Prof. Drummond explains in a simple yet engaging way why demonstrating value of new interventions has become so important. Dove 2022-09-29 /pmc/articles/PMC9532943/ /pubmed/36213303 http://dx.doi.org/10.2147/IJGM.S389025 Text en © 2022 Boehringer Ingelheim International GmbH. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Commentary
Drummond, Michael F
Hartgers-Gubbels, Elisabeth Sophia
Chambers, Michael
Value Insider Season 1 Episode 1: The Importance of Payers and HTA: How Did We End Up Here? (Introduction to Value) [Podcast]
title Value Insider Season 1 Episode 1: The Importance of Payers and HTA: How Did We End Up Here? (Introduction to Value) [Podcast]
title_full Value Insider Season 1 Episode 1: The Importance of Payers and HTA: How Did We End Up Here? (Introduction to Value) [Podcast]
title_fullStr Value Insider Season 1 Episode 1: The Importance of Payers and HTA: How Did We End Up Here? (Introduction to Value) [Podcast]
title_full_unstemmed Value Insider Season 1 Episode 1: The Importance of Payers and HTA: How Did We End Up Here? (Introduction to Value) [Podcast]
title_short Value Insider Season 1 Episode 1: The Importance of Payers and HTA: How Did We End Up Here? (Introduction to Value) [Podcast]
title_sort value insider season 1 episode 1: the importance of payers and hta: how did we end up here? (introduction to value) [podcast]
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532943/
https://www.ncbi.nlm.nih.gov/pubmed/36213303
http://dx.doi.org/10.2147/IJGM.S389025
work_keys_str_mv AT drummondmichaelf valueinsiderseason1episode1theimportanceofpayersandhtahowdidweenduphereintroductiontovaluepodcast
AT hartgersgubbelselisabethsophia valueinsiderseason1episode1theimportanceofpayersandhtahowdidweenduphereintroductiontovaluepodcast
AT chambersmichael valueinsiderseason1episode1theimportanceofpayersandhtahowdidweenduphereintroductiontovaluepodcast

Ejemplares similares